Chancery Court Tosses Stockholder Complaint Against Ultragenyx Pharma
The Delaware Chancery Court shot down an investor lawsuit alleging excessive compensation to non-employee directors of Ultragenyx Pharmaceutical, finding that a pre-suit demand letter rejected by the board sunk the stockholder’s legal options.
Read more